Antivirale Nukleosid-Derivate
European patent · EP0393920 · Deleted
Register entry
- Publication number
- EP0393920
- Application number
- EP90303904
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Apr 11, 1990
- Published
- Oct 24, 1990
- Granted
- Jul 9, 1997
- Deleted
- Apr 10, 2010
- Reason
- Maximum term reached
- IPC classes
- C07H 19/06 (2006.01)C07D 473/00 (2006.01)A61K 31/70 (2006.01)A61K 31/52 (2006.01)
- Priority
- GB 8908646 17.04.1989GB 8921266 20.09.1989
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 12, 2010
Maximum term reached
Published in Swissreg on 12.04.2010
- Oct 31, 2005
Transferred
- Owner
- Scotia Holdings plc, Efamol House, Woodbridge Meadows, Guildford (Surrey GU1 1BA), United Kingdom → PROTARGA, INC., 2200 Renaissance Blvd., Suite 450, King of Prussia, PA 19406, USA
Published in +pat+ No 20 in 2005
- Oct 31, 2005
Transferred
- Owner
- PROTARGA, INC., 2200 Renaissance Blvd., Suite 450, King of Prussia, PA 19406, USA → Luitpold Pharmaceuticals, Inc., One Luitpold Drive, Shirley, NY 11967, USA
Published in +pat+ No 20 in 2005
- Jul 15, 1997
Agent entered
- Representative
- R. A. Egli & Co., Patentanwälte, Horneggstrasse 4, 8008 Zürich
Published in PIDTJ No 13 in 1997
- Jul 15, 1997
Granted
Published in PIDTJ No 13 in 1997
Parties
Inventor
Horrobin, David Frederick, Scotia
Guildford, Surrey GU1 1BA, GB
Stewart, John Charles Marshall, Scotia
Guildford, Surrey GU1 1BA, GB
Winther, Michael David, Scotia
Guildford, Surrey GU1 1BA, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.